Facial Injectables Market Size

Facial Injectables Market Size

Facial Injectables Market size was valued at USD 9.4 billion in 2023 and is estimated to grow at 10.3% CAGR from 2024 to 2032. Facial injectables are non-surgical cosmetic treatments used to enhance facial features or address signs of aging. They are typically administered via injections into specific areas of the face.

To get key market trends

  Download Free Sample

Populations in many parts of the world are aging, driving an increasing demand for anti-aging treatments. The geriatric demographic seeks aesthetic procedures to maintain a youthful appearance and combat signs of aging such as wrinkles, fine lines, and volume loss. For instance, the World Health Organization (WHO) projects that by 2030, one out of every six individuals globally will be aged 60 years or older.

 

During this period, the proportion of the population aged 60 years and above will rise from 1 billion in 2020 to 1.4 billion. By 2050, the worldwide population of individuals aged 60 years and older will double, reaching 2.1 billion. Additionally, the number of individuals aged 80 years or older is anticipated to triple between 2020 and 2050, reaching 426 million. Therefore, this demographic shift creates a significant market opportunity for facial injectables and other aesthetic medicine which is estimated to reach USD 52.4 billion by 2032.

Furthermore, continuous advancements in technology have led to the development of more effective and safer facial injectables. New formulations, delivery systems, and techniques allow for better results, increased precision, and reduced side effects, making these treatments more appealing to a broader range of patients.